Physician profile
Mohammad Wada
NPI 1477785186
$17,712.37
in general payments reported to CMS, 2019-2025
58 companies · $1,848 in 2025
The $1,848 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,188 · 2020: $2,182 · 2021: $2,228 · 2022: $1,762 · 2023: $1,483 · 2024: $1,021 · 2025: $1,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,210 · Education: $121 · Travel and Lodging: $20.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,210.41 |
| Education | $121.09 |
| Travel and Lodging | $20.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,873.29 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $1,106.08 | 2019-2024 | Senza |
| Medtronic USA, INC. | $933.11 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $909.94 | 2019-2025 | Relistor |
| Relievant Medsystems, INC. | $599.96 | 2022-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $564.37 | 2019-2025 | Belbuca |
| Abbott Laboratories | $548.12 | 2021-2024 | Eterna, Proclaim |
| Abbvie INC. | $481.38 | 2021-2025 | Botox |
| Globus Medical, INC. | $415.32 | 2025 | Senza, Vyrsa V1 |
| Medtronic, INC. | $360.17 | 2021-2025 | Inceptiv, Accurian |
| Horizon Therapeutics Plc | $351.64 | 2019-2022 | |
| Saluda Medical Americas, INC. | $349.68 | 2022-2025 | Evoke, Evoke Scs |
| Avanos Medical | $311.92 | 2019-2024 | Standard Rf Disposables |
| Nalu Medical, INC. | $284.58 | 2021-2024 | Nalu Neurostimulation System |
| Vertiflex, INC. | $264.55 | 2019 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Wada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.